Hisada Tomoka, Sawaki Masataka, Ishiguro Junko, Adachi Yayoi, Kotani Haruru, Yoshimura Akiyo, Hattori Masaya, Yatabe Yasushi, Iwata Hiroji
Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi 464-8681, Japan.
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Aichi 464-8681, Japan.
Mol Clin Oncol. 2016 Sep;5(3):269-272. doi: 10.3892/mco.2016.948. Epub 2016 Jul 4.
A positive resection margin is one of the most significant risk factors for local breast cancer recurrence following breast-conserving surgery (BCS). Intraoperative specimen mammography (SMMG) is routinely used to evaluate the surgical margin at our institution. The aim of the present study was to assess the adequacy of SMMG for margin assessment. The patient cohort included 174 women who underwent BCS in 2006. The sensitivity and specificity of SMMG were assessed by comparing the margins assessed by histological and radiological methods. It was also examined whether the rate of positive histological margins was decreased by re-excision following SMMG evaluation. A total of 23 false-negatives and 6 false-positives were determined by SMMG. The sensitivity and specificity of SMMG margin assessment for patients with primary breast cancer were 20.6 and 94.6%, respectively. The positive predictive value was 50% and the negative predictive value was 82.2%. A subgroup analysis revealed that the sensitivity and specificity of SMMG in cases with ductal carcinoma (DCIS) were higher compared with those in invasive ductal carcinoma. Furthermore, the positive histological margin rate was not affected by re-excision. Although the general usefulness of intraoperative SMMG was not proven, this procedure may be useful in specific cases, particularly those with DCIS and those diagnosed by stereotactic biopsy. A prospective study with exact criteria and a standard procedure is required.
切缘阳性是保乳手术(BCS)后局部乳腺癌复发的最重要危险因素之一。术中标本乳腺摄影(SMMG)在我们机构常规用于评估手术切缘。本研究的目的是评估SMMG用于切缘评估的充分性。患者队列包括2006年接受BCS的174名女性。通过比较组织学和放射学方法评估的切缘来评估SMMG的敏感性和特异性。还检查了在SMMG评估后再次切除是否降低了组织学切缘阳性率。SMMG共确定了23例假阴性和6例假阳性。SMMG对原发性乳腺癌患者切缘评估的敏感性和特异性分别为20.6%和94.6%。阳性预测值为50%,阴性预测值为82.2%。亚组分析显示,与浸润性导管癌相比,SMMG在导管原位癌(DCIS)病例中的敏感性和特异性更高。此外,再次切除并未影响组织学切缘阳性率。虽然术中SMMG的总体有用性尚未得到证实,但该程序在特定病例中可能有用,特别是那些患有DCIS的病例以及通过立体定向活检诊断的病例。需要进行一项具有确切标准和标准程序的前瞻性研究。